TY - JOUR
T1 - Bone dynamics and inflammation
T2 - lessons from rare diseases
AU - Matsumoto, Yoshinori
AU - Rottapel, Robert
N1 - Publisher Copyright:
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of the Japanese Society of Clinical Immunology.
PY - 2020/4/2
Y1 - 2020/4/2
N2 - The adaptor protein 3BP2 (SH3-domain binding protein 2), which is encoded by the SH3BP2 locus, nucleates a signaling complex comprising ABL, SRC, VAV, and SYK, and facilitates an open active configuration of these proteins, leading to their kinase activation. Gain-of-function missense mutations in the SH3BP2 gene cause cherubism, an autosomal dominant disorder associated with severe craniofacial developmental defects in children. Previous studies have demonstrated that 3BP2 and its degradation pathway regulate bone metabolism, energy metabolism, and inflammation and that dysregulation of the 3BP2 degradation pathway is associated with human disorders. Herein, we discussed lessons from cherubism indicating that 3BP2 studies could elucidate the pathogenesis of bone loss caused by inflammation and identify suitable therapeutic targets.
AB - The adaptor protein 3BP2 (SH3-domain binding protein 2), which is encoded by the SH3BP2 locus, nucleates a signaling complex comprising ABL, SRC, VAV, and SYK, and facilitates an open active configuration of these proteins, leading to their kinase activation. Gain-of-function missense mutations in the SH3BP2 gene cause cherubism, an autosomal dominant disorder associated with severe craniofacial developmental defects in children. Previous studies have demonstrated that 3BP2 and its degradation pathway regulate bone metabolism, energy metabolism, and inflammation and that dysregulation of the 3BP2 degradation pathway is associated with human disorders. Herein, we discussed lessons from cherubism indicating that 3BP2 studies could elucidate the pathogenesis of bone loss caused by inflammation and identify suitable therapeutic targets.
KW - 3BP2
KW - cherubism
KW - osteoclastogenesis
UR - http://www.scopus.com/inward/record.url?scp=85079171301&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079171301&partnerID=8YFLogxK
U2 - 10.1080/25785826.2020.1720104
DO - 10.1080/25785826.2020.1720104
M3 - Review article
C2 - 31999934
AN - SCOPUS:85079171301
SN - 0911-4300
VL - 43
SP - 61
EP - 64
JO - Immunological Medicine
JF - Immunological Medicine
IS - 2
ER -